These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 16279808
1. Synthesis of two 3,5-disubstituted sulfonamide catechol ligands and evaluation of their iron(III) complexes for use as MRI contrast agents. Schwert DD, Richardson N, Ji G, Radüchel B, Ebert W, Heffner PE, Keck R, Davies JA. J Med Chem; 2005 Nov 17; 48(23):7482-5. PubMed ID: 16279808 [Abstract] [Full Text] [Related]
2. [Synthesis, characterization and relaxivity of dimeric DTPA-gadonium (III) complexes with long chain alkyl esters of L-lysine]. Yu KC, Liu LY, Wan FX, Zhou JL, Ding SW, Ye CH. Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Apr 17; 26(4):670-3. PubMed ID: 16836136 [Abstract] [Full Text] [Related]
3. Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes. Doble DM, Melchior M, O'Sullivan B, Siering C, Xu J, Pierre VC, Raymond KN. Inorg Chem; 2003 Aug 11; 42(16):4930-7. PubMed ID: 12895117 [Abstract] [Full Text] [Related]
4. Iron(III) complexes of tridentate 3N ligands as functional models for catechol dioxygenases: the role of ligand N-alkyl substitution and solvent on reaction rate and product selectivity. Visvaganesan K, Mayilmurugan R, Suresh E, Palaniandavar M. Inorg Chem; 2007 Nov 26; 46(24):10294-306. PubMed ID: 17958355 [Abstract] [Full Text] [Related]
5. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents. Yan GP, Hu B, Liu ML, Li LY. J Pharm Pharmacol; 2005 Mar 26; 57(3):351-7. PubMed ID: 15807991 [Abstract] [Full Text] [Related]
6. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. Puerta DT, Botta M, Jocher CJ, Werner EJ, Avedano S, Raymond KN, Cohen SM. J Am Chem Soc; 2006 Feb 22; 128(7):2222-3. PubMed ID: 16478170 [Abstract] [Full Text] [Related]
7. Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates. Crisponi G, Nurchi VM, Pivetta T. J Inorg Biochem; 2008 Feb 22; 102(2):209-15. PubMed ID: 17854902 [Abstract] [Full Text] [Related]
8. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents. Kim BH, Lee N, Kim H, An K, Park YI, Choi Y, Shin K, Lee Y, Kwon SG, Na HB, Park JG, Ahn TY, Kim YW, Moon WK, Choi SH, Hyeon T. J Am Chem Soc; 2011 Aug 17; 133(32):12624-31. PubMed ID: 21744804 [Abstract] [Full Text] [Related]
9. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones. Rai BL, Dekhordi LS, Khodr H, Jin Y, Liu Z, Hider RC. J Med Chem; 1998 Aug 27; 41(18):3347-59. PubMed ID: 9719587 [Abstract] [Full Text] [Related]
11. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands. Pierre VC, Melchior M, Doble DM, Raymond KN. Inorg Chem; 2004 Dec 27; 43(26):8520-5. PubMed ID: 15606201 [Abstract] [Full Text] [Related]
12. Modeling the 2-His-1-carboxylate facial triad: iron-catecholato complexes as structural and functional models of the extradiol cleaving dioxygenases. Bruijnincx PC, Lutz M, Spek AL, Hagen WR, Weckhuysen BM, van Koten G, Gebbink RJ. J Am Chem Soc; 2007 Feb 28; 129(8):2275-86. PubMed ID: 17266307 [Abstract] [Full Text] [Related]
13. Gd-complexes of DTPA-bis(amide) conjugates of tranexamic acid and its esters with high relaxivity and stability for magnetic resonance imaging. Dutta S, Park JA, Jung JC, Chang Y, Kim TJ. Dalton Trans; 2008 Apr 28; (16):2199-206. PubMed ID: 18398546 [Abstract] [Full Text] [Related]
14. One-pot synthesis of pegylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents. Lutz JF, Stiller S, Hoth A, Kaufner L, Pison U, Cartier R. Biomacromolecules; 2006 Nov 28; 7(11):3132-8. PubMed ID: 17096542 [Abstract] [Full Text] [Related]
15. A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging. Mishra A, Pfeuffer J, Mishra R, Engelmann J, Mishra AK, Ugurbil K, Logothetis NK. Bioconjug Chem; 2006 Nov 28; 17(3):773-80. PubMed ID: 16704217 [Abstract] [Full Text] [Related]
16. Iron-based second-sphere contrast agents for magnetic resonance imaging: development of a model system and evaluation of iron (III) tris (tironate) complex in rats. Davies JA, Dutremez SG, Hockensmith CM, Keck R, Richardson N, Selman S, Smith DA, Ulmer CW, Wheatley LS, Zeiss J. Acad Radiol; 1996 Nov 28; 3(11):936-45. PubMed ID: 8959184 [Abstract] [Full Text] [Related]
18. Vesicles to concentrate iron in low-iron media: an attempt to mimic marine siderophores. Bednarova L, Brandel J, d'Hardemare Adu M, Bednar J, Serratrice G, Pierre JL. Chemistry; 2008 Nov 28; 14(12):3680-6. PubMed ID: 18293349 [Abstract] [Full Text] [Related]
19. Gadolinium(III) complexes as MRI contrast agents: ligand design and properties of the complexes. Hermann P, Kotek J, Kubícek V, Lukes I. Dalton Trans; 2008 Jun 21; (23):3027-47. PubMed ID: 18521444 [Abstract] [Full Text] [Related]
20. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract. Babos M, Schwarcz A, Randhawa MS, Marton B, Kardos L, Palkó A. Eur J Radiol; 2008 Jan 21; 65(1):133-9. PubMed ID: 17485189 [Abstract] [Full Text] [Related] Page: [Next] [New Search]